分享至
来源：财华网
【財華社訊】从事神经和外周血管介入医疗器械的归创通桥(02190.HK)今日截止孖展认购。综合多间券商数据显示，估计最少借出1000亿元孖展额，以公开发售集资额2.56亿元计算，超额认购约390倍。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
